BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29543557)

  • 21. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.
    Walker AW; Sanderson JD; Churcher C; Parkes GC; Hudspith BN; Rayment N; Brostoff J; Parkhill J; Dougan G; Petrovska L
    BMC Microbiol; 2011 Jan; 11():7. PubMed ID: 21219646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
    J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metagenomic analysis of intestinal mucosa revealed a specific eukaryotic gut virome signature in early-diagnosed inflammatory bowel disease.
    Ungaro F; Massimino L; Furfaro F; Rimoldi V; Peyrin-Biroulet L; D'Alessio S; Danese S
    Gut Microbes; 2019; 10(2):149-158. PubMed ID: 30252582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.
    Ott SJ; Musfeldt M; Wenderoth DF; Hampe J; Brant O; Fölsch UR; Timmis KN; Schreiber S
    Gut; 2004 May; 53(5):685-93. PubMed ID: 15082587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis.
    Shah R; Cope JL; Nagy-Szakal D; Dowd S; Versalovic J; Hollister EB; Kellermayer R
    Gut Microbes; 2016 Sep; 7(5):384-96. PubMed ID: 27217061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.
    Ringel Y; Maharshak N; Ringel-Kulka T; Wolber EA; Sartor RB; Carroll IM
    Gut Microbes; 2015; 6(3):173-81. PubMed ID: 25915459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ecological and network analyses identify four microbial species with potential significance for the diagnosis/treatment of ulcerative colitis (UC).
    Li W; Sun Y; Dai L; Chen H; Yi B; Niu J; Wang L; Zhang F; Luo J; Wang K; Guo R; Li L; Zou Q; Ma ZS; Miao Y
    BMC Microbiol; 2021 May; 21(1):138. PubMed ID: 33947329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fungal microbiota dysbiosis in IBD.
    Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
    Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colonic Mucosal Epigenome and Microbiome Development in Children and Adolescents.
    Harris RA; Shah R; Hollister EB; Tronstad RR; Hovdenak N; Szigeti R; Versalovic J; Kellermayer R
    J Immunol Res; 2016; 2016():9170162. PubMed ID: 27006956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota.
    Altomare A; Putignani L; Del Chierico F; Cocca S; Angeletti S; Ciccozzi M; Tripiciano C; Dalla Piccola B; Cicala M; Guarino MPL
    Dig Liver Dis; 2019 May; 51(5):648-656. PubMed ID: 30573380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiome diversity in acute infective and chronic inflammatory gastrointestinal diseases in North India.
    Kedia S; Rampal R; Paul J; Ahuja V
    J Gastroenterol; 2016 Jul; 51(7):660-71. PubMed ID: 26994772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The predominant site of bacterial translocation across the intestinal mucosal barrier occurs at the advancing disease margin in Crohn's disease.
    Chiodini RJ; Dowd SE; Galandiuk S; Davis B; Glassing A
    Microbiology (Reading); 2016 Sep; 162(9):1608-1619. PubMed ID: 27418066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
    Merga Y; Campbell BJ; Rhodes JM
    Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A microbial signature for Crohn's disease.
    Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
    Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of universal gut microbial biomarkers of common human intestinal diseases by meta-analysis.
    Mancabelli L; Milani C; Lugli GA; Turroni F; Cocconi D; van Sinderen D; Ventura M
    FEMS Microbiol Ecol; 2017 Dec; 93(12):. PubMed ID: 29126267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease.
    Ricanek P; Lothe SM; Szpinda I; Jorde AT; Brackmann S; Perminow G; Jørgensen KK; Rydning A; Vatn MH; Tønjum T;
    J Crohns Colitis; 2010 Nov; 4(5):561-6. PubMed ID: 21122560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.